Lubiprostone 70771-1763
Product NDC
70771-1763- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 23, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA214131
Need to source Lubiprostone? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lubiprostone | 8 ug/1 |
Drug Class
Chloride Channel Activator [EPC]Chloride Channel Activator [EPC]Chloride Channel Activators [MoA]
Packaging Options(2)
100 CAPSULE in 1 BOTTLE (70771-1763-1)
60 CAPSULE in 1 BOTTLE (70771-1763-6)